Radiopharmaceuticals market tracks 8% CAGR as size nears $11.66b

The forecast shows steady expansion from $6.76b 2022 base.

The global radiopharmaceuticals market is projected to expand at a compound annual growth rate (CAGR) of 8.0% over the 2023–2029 forecast period, according to a market research report released by Valuates Reports.

The report estimates the market was valued at $6.76b in 2022 and is expected to reach $11.66b by 2029, indicating sustained growth across the period.

Valuates Reports said the forecast reflects analysis of market opportunities, trends and competitive dynamics across key regions and product segments covered in the study.

The findings are intended to support strategic planning by industry participants and investors assessing medium-term growth prospects in the radiopharmaceuticals sector, according to the report.